SINGAPORE (Oct 22): UOB Kay Hian is reiterating its “buy” recommendation on Asian Healthcare Specialists (AHS) with an unchanged target price of 33 cents following the orthopaedic group’s proposed issuance of convertible bond and grant of share option to Temasek Holdings-linked Vanda 1.

Have a premium account? Sign in to continue reading.

Unlimited access to all stories from $99.9/year*

The latest reporting and analysis from business and investments to news and views on social issues.


  • Simultaneous logins across all devices
  • Instant access to past digital issues
  • Unlimited access to The Edge Malaysia
  • *For annual subscription plan only. T&Cs apply